| 摘要: |
| [目的] 评估督灸联合穴位埋线治疗脾肾阳虚型产后肥胖的临床疗效。[方法] 采用前瞻性、单中心、随机对照临床试验，纳入2022年11月—2024年6月接受治疗并完成6个月随访的92例脾肾阳虚型产后肥胖患者，随机分为电针组（24例）、督灸组（32例）和督灸结合穴位埋线组（结合组，36例），各组均接受3个疗程的治疗。统计治疗前后体质量（BW）、身体质量指数（BMI）、腰围（WC）、腰臀比（WHR）、中医证候积分及不良反应等。[结果] 结合组的BMI、臀围（HC）等核心指标在时间与组别交互效应均显著改善（P<0.05）。3组间比较显示，结合组在治疗后及随访各时间点的BW（66.26~63.00 kg）、BMI （26.31~24.33 kg/m2）和WC（82.11~79.00 cm）改善均显著优于电针组和督灸组（P<0.05），在随访6个月时WHR（0.69±0.04）显著优于电针组和督灸组（P<0.05）。此外，治疗后及随访各时间点，结合组的证候积分改善率时间与组别交互效应明显优于其他两组（P<0.05），总不良反应发生率最低（52.78%）且无重度不良反应情况。[结论] 本研究初步表明，督灸联合穴位埋线能有效改善脾肾阳虚型产后肥胖患者的BW、BMI、WC、WHR及中医证候，疗效优于单纯电针或督灸治疗，且安全性良好。其优势源于督灸的即时温补与穴位埋线的长效刺激协同作用，值得临床推广。 |
| 关键词: 督灸 穴位埋线 电针 产后肥胖 脾肾阳虚型 随机对照试验 |
| DOI：10.11656/j.issn.1672-1519.2026.07.06 |
| 分类号:R589.2 |
| 基金项目:2023年重庆市科卫联合中医药科研项目（2023QNXM070）。 |
|
| Randomized controlled trial of governor vessel moxibustion combined with acupoint embedding therapy for postpartum obesity with spleen-kidney yang deficiency type |
|
HUANG Zhaolan, YANG Darong
|
|
Department of Rehabilitation, Chongqing Bishan District Hospital of Traditional Chinese Medicine(Bishan Hospital, Chongqing University of Chinese Medicine), Chongqing 402760, China
|
| Abstract: |
| [Objective] To Evaluate the clinical efficacy of governor vessel moxibustion combined with acupoint embedding for postpartum obesity with spleen-kidney yang deficiency. A prospective，single-center，randomized controlled clinical trial. [Methods] A total of 92 patients with postpartum obesity of spleen-kidney yang deficiency type who received treatment from November 2022 to June 2024 and completed 6-month follow-up were enrolled. Participants were divided into an electroacupuncture group（24 cases），governor vessel moxibustion group（32 cases），and a combined group receiving both governor vessel moxibustion and acupoint embedding （36 cases）. All groups received three treatment courses. Parameters including body weight（BW），body mass index（BMI），waist circumference（WC），waist-to-hip ratio（WHR），traditional Chinese medicine（TCM）syndrome scores，and adverse reactions were statistically analyzed before and after treatment. [Results] For the combined therapy group，significant improvements in core indicators such as BMI and hip circumference（HC）were observed in the time and group interaction effects（P<0.05）. Inter-group comparisons revealed that the combined therapy group showed significantly greater improvements in BW（66.26 to 63.00 kg），BMI （26.31 to 24.33 kg/m2），and WC（82.11 to 79.00 cm）at post-treatment and all follow-up time points compared to both the electro-acupuncture and governor vessel moxibustion groups（P<0.05）. At the 6 -month follow-up，the WHR（0.69 ± 0.04）of the combined therapy group was also significantly better than that of the other two groups（P<0.05）. Furthermore，at post-treatment and all follow-up time points，the improvement rate of symptom scores in the combined therapy group demonstrated a significantly superior time and group interaction effect compared to the other two groups（P<0.05），with the lowest overall incidence of adverse events（52.78%）and no occurrence of severe adverse events. [Conclusion] This study preliminarily demonstrates that governor vessel moxibustion and acupoint embedding can effectively improve BW，BMI，WC，WHR，and TCM syndrome scores in patients with postpartum obesity of spleen-kidney yang deficiency type. Its therapeutic efficacy is superior to electroacupuncture or governor vessel moxibustion alone， with a favorable safety profile. The advantage stems from the synergistic effect between the immediate warming and tonifying action of governor vessel moxibustion and the sustained stimulation of acupoint embedding，making it worthy of clinical promotion. |
| Key words: governor vessel moxibustion acupoint embedding electroacupuncture postpartum obesity spleen-kidney yang deficiency type randomized controlled trial |
